Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy

被引:0
|
作者
Manisha Korb
Allison Peck
Lindsay N. Alfano
Kenneth I. Berger
Meredith K. James
Nupur Ghoshal
Elise Healzer
Claire Henchcliffe
Shaida Khan
Pradeep P. A. Mammen
Sujata Patel
Gerald Pfeffer
Stuart H. Ralston
Bhaskar Roy
William W. Seeley
Andrea Swenson
Tahseen Mozaffar
Conrad Weihl
Virginia Kimonis
机构
[1] University of California - Irvine School of Medicine,Department of Neurology
[2] University of California - Irvine School of Medicine,Department of Pediatrics
[3] University of California - Irvine School of Medicine,Department of Pathology & Laboratory Medicine
[4] Cure VCP Disease,Department of Medicine (Pulmonary)
[5] The Abigail Wexner Research Institute at Nationwide Children’s Hospital,The John Walton Muscular Dystrophy Research Centre
[6] NYU Grossman School of Medicine,Department of Neurology and Psychiatry
[7] Newcastle University and Newcastle Hospitals NHS Foundation Trust,Department of Neurology & Neurotherapeutics
[8] Washington University in St. Louis,Department of Medicine (Cardiology)
[9] Thriving Hope Consulting,Hotchkiss Brain Institute
[10] University of Texas Southwestern Medical Center,Department of Neurology
[11] University of Texas Southwestern Medical Center,Weill Institute for Neurosciences
[12] Wellness with Sujata,Department of Neurology
[13] University of Calgary Cumming School of Medicine,Department of Neurology
[14] Institute of Genetics and Cancer at the University of Edinburgh,The Hope Center
[15] Yale School of Medicine,undefined
[16] University of California San Francisco,undefined
[17] University of Iowa Hospitals and Clinics,undefined
[18] Washington University in St. Louis,undefined
[19] Washington University in St. Louis,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Valosin-containing protein (VCP) associated multisystem proteinopathy (MSP) is a rare inherited disorder that may result in multisystem involvement of varying phenotypes including inclusion body myopathy, Paget’s disease of bone (PDB), frontotemporal dementia (FTD), parkinsonism, and amyotrophic lateral sclerosis (ALS), among others. An international multidisciplinary consortium of 40+ experts in neuromuscular disease, dementia, movement disorders, psychology, cardiology, pulmonology, physical therapy, occupational therapy, speech and language pathology, nutrition, genetics, integrative medicine, and endocrinology were convened by the patient advocacy organization, Cure VCP Disease, in December 2020 to develop a standard of care for this heterogeneous and under-diagnosed disease. To achieve this goal, working groups collaborated to generate expert consensus recommendations in 10 key areas: genetic diagnosis, myopathy, FTD, PDB, ALS, Charcot Marie Tooth disease (CMT), parkinsonism, cardiomyopathy, pulmonology, supportive therapies, nutrition and supplements, and mental health. In April 2021, facilitated discussion of each working group’s conclusions with consensus building techniques enabled final agreement on the proposed standard of care for VCP patients. Timely referral to a specialty neuromuscular center is recommended to aid in efficient diagnosis of VCP MSP via single-gene testing in the case of a known familial VCP variant, or multi-gene panel sequencing in undifferentiated cases. Additionally, regular and ongoing multidisciplinary team follow up is essential for proactive screening and management of secondary complications. The goal of our consortium is to raise awareness of VCP MSP, expedite the time to accurate diagnosis, define gaps and inequities in patient care, initiate appropriate pharmacotherapies and supportive therapies for optimal management, and elevate the recommended best practices guidelines for multidisciplinary care internationally.
引用
收藏
相关论文
共 50 条
  • [1] Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy
    Korb, M.
    Peck, A.
    Berger, K.
    James, M.
    Ghoshal, N.
    Healzer, E.
    Henchcliffe, C.
    Khan, S.
    Mammen, P.
    Patel, S.
    Pfeffer, G.
    Ralston, S.
    Roy, B.
    Seeley, B.
    Swenson, A.
    Mozaffar, T.
    Weihl, C.
    Kimonis, V.
    Alfano, L.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S155 - S156
  • [2] Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy
    Korb, Manisha
    Peck, Allison
    Alfano, Lindsay N.
    Berger, Kenneth, I
    James, Meredith K.
    Ghoshal, Nupur
    Healzer, Elise
    Henchcliffe, Claire
    Khan, Shaida
    Mammen, Pradeep P. A.
    Patel, Sujata
    Pfeffer, Gerald
    Ralston, Stuart H.
    Roy, Bhaskar
    Seeley, William W.
    Swenson, Andrea
    Mozaffar, Tahseen
    Weihl, Conrad
    Kimonis, Virginia
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [3] Novel valosin-containing protein mutations associated with multisystem proteinopathy
    Al-Tahan, Sejad
    Al-Obeidi, Ebaa
    Yoshioka, Hiroshi
    Lakatos, Anita
    Weiss, Lan
    Grafe, Marjorie
    Palmio, Johanna
    Wicklund, Matt
    Harati, Yadollah
    Omizo, Molly
    Udd, Bjarne
    Kimonis, Virginia
    NEUROMUSCULAR DISORDERS, 2018, 28 (06) : 491 - 501
  • [4] Therapeutic developments for valosin-containing protein mediated multisystem proteinopathy
    Boock, Victoria
    Roy, Bhaskar
    Pfeffer, Gerald
    Kimonis, Virginia
    CURRENT OPINION IN NEUROLOGY, 2023, 36 (05) : 432 - 440
  • [5] Genotype-phenotype study in patients with valosin-containing protein mutations associated with multisystem proteinopathy
    Al-Obeidi, E.
    Al-Tahan, S.
    Surampalli, A.
    Goyal, N.
    Wang, A. K.
    Hermann, A.
    Omizo, M.
    Smith, C.
    Mozaffar, T.
    Kimonis, V.
    CLINICAL GENETICS, 2018, 93 (01) : 119 - 125
  • [6] Clinical and Electrophysiological Presentation of a Patient with Multisystem Proteinopathy Associated with Valosin-Containing Protein Mutation
    Halber, Matthew
    Bulancea, Sabrina
    Treidler, Simona
    NEUROLOGY, 2023, 100 (17)
  • [7] Clinical classification of variants in the valosin containing protein gene associated with multisystem proteinopathy
    Manera, J. Diaz
    Schiava, M.
    Ikenaga, C.
    Stojkovic, T.
    Nishino, I.
    Nair, S.
    Manousakis, G.
    Quinn, C.
    Sahenk, Z.
    Monforte, M.
    Oldfors, A.
    Pal, E.
    Velez Gomez, B.
    De Bleecker, J.
    Farrugia, M.
    Harms, M.
    Ralston, S.
    Sotoca Fernandez, J.
    Bevilacqua, J.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S118 - S119
  • [8] Clinical trial readiness and validation of onsite and remote evaluation in valosin-containing protein-associated multisystem proteinopathy: a 24-month longitudinal study
    Reash, N.
    Iammarino, M.
    Pietruszewski, L.
    Lowes, L.
    Mendell, J.
    Connolly, A.
    Adderley, K.
    Peck, N.
    Peck, A.
    Alfano, L.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S68 - S68
  • [9] Clinical trial readiness and validation of onsite and remote evaluation in valosin containing protein-associated multisystem proteinopathy
    Alfano, L.
    Peck, A.
    Iammarino, M.
    Patel, S.
    Reash, N.
    Almomen, M.
    Mendell, J.
    Sabo, B.
    Long, A.
    Pietruszewski, L.
    Lowes, L.
    Peck, N.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S119 - S119
  • [10] Valosin-Containing Protein is a Novel Autoantigen in Patients with Glaucoma
    Lee, Koon-Ja
    Jeong, Seon-Mi
    Hoehn, Benjamin Douglass
    Hong, Young Jae
    Lee, Sung Ho
    OPTOMETRY AND VISION SCIENCE, 2011, 88 (01) : 164 - 172